Us Drug Regulators
- All
- News
- Videos
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
1st Over-The-Counter Birth Control Pill Approved In US
The US drug regulator approved the first over-the-counter birth control pill in the country, it announced Thursday, dramatically widening access to contraception for women as the United States grapples with reproductive rights.
-
US Makes New Alzheimer's Drug More Widely Accessible
The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
US Health Regulator Lists 378 Hand Sanitisers Consumers Should Not Use
Amid rising COVID-19 cases in China, the US Food and Drug Administration (FDA) released a list of hand sanitisers it recommends avoiding.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
LASIK Patients Should Be Warned of Risks Before Eye Procedure, Says US Health Regulator
LASIK - Laser-Assisted In Situ Keratomileusis - is the most commonly performed laser refractive surgery used to correct common vision problems. However, the surgery is now under the lens of the US Food and Drug Administration (FDA).
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
1st Over-The-Counter Birth Control Pill Approved In US
The US drug regulator approved the first over-the-counter birth control pill in the country, it announced Thursday, dramatically widening access to contraception for women as the United States grapples with reproductive rights.
-
US Makes New Alzheimer's Drug More Widely Accessible
The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
US Health Regulator Lists 378 Hand Sanitisers Consumers Should Not Use
Amid rising COVID-19 cases in China, the US Food and Drug Administration (FDA) released a list of hand sanitisers it recommends avoiding.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
LASIK Patients Should Be Warned of Risks Before Eye Procedure, Says US Health Regulator
LASIK - Laser-Assisted In Situ Keratomileusis - is the most commonly performed laser refractive surgery used to correct common vision problems. However, the surgery is now under the lens of the US Food and Drug Administration (FDA).
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
